Opioid and CB1 receptors involvement in central anti-nociceptive effect of vitamin C in the formalin-induced pain model in rats
Although the analgesic effect of vitamin C was reported in several studies, its supra-spinal analgesia and the involved mechanisms have not been investigated yet. In this study, central effect of vitamin C in formalin-induced pain was investigated. Naloxone (an opioid receptor antagonist) and AM251 (a CB1 receptor antagonist) were used to clarify the possible mechanism of this vitamin.
In ketamine-xylazine anesthetized rats, one stainless-steel guide cannula was implanted into the fourth ventricle of the brain. The formalin test was induced by intra-plantar injection of formalin (50 mL, 2.5%), and the time spent licking and biting of the injected paw was recorded for 1 h.
A marked biphasic (first phase: 0–5 min and second phase: 15–50 min) pain response was induced after formalin injection. Intra-fourth ventricle injection of vitamin C significantly (p < 0.05) decreased both phases of pain. Naloxone and AM251 had no effect on the pain intensity. However, the analgesic effect of vitamin C was inhibited by pretreatments with naloxone and AM251. All the above-mentioned treatments did not alter locomotor activity of the animals.
These results showed that vitamin C suppresses formalin-induced neurogenic and inflammatory pains in rats through central modulatory mechanisms. Opioid and cannabinoid receptors play a role in the analgesic effects of vitamin C.
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.